XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at beginning of period at Dec. 31, 2023 $ 308 $ 156,678 $ (123,640) $ (1,912) $ 31,434
Balance at beginning of period (in shares) at Dec. 31, 2023 30,812,329        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     5,846   5,846
Unrealized (loss) income on foreign exchange rate translation       (160) (160)
Dividends     (9,860)   (9,860)
Balance at end of period at Mar. 31, 2024 $ 308 156,678 (127,654) (2,072) 27,260
Balance at end of period (in shares) at Mar. 31, 2024 30,812,329        
Balance at beginning of period at Dec. 31, 2023 $ 308 156,678 (123,640) (1,912) 31,434
Balance at beginning of period (in shares) at Dec. 31, 2023 30,812,329        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income         (3,317)
Balance at end of period at Sep. 30, 2024 $ 309 156,905 (136,817) (2,153) 18,244
Balance at end of period (in shares) at Sep. 30, 2024 30,906,777        
Balance at beginning of period at Mar. 31, 2024 $ 308 156,678 (127,654) (2,072) 27,260
Balance at beginning of period (in shares) at Mar. 31, 2024 30,812,329        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     (3,546)   (3,546)
Unrealized (loss) income on foreign exchange rate translation       (110) (110)
Issuance of common stock as compensation $ 1 258     259
Issuance of common stock as compensation (in shares) 133,850        
Shares exchanged for taxes on stock-based compensation   (76)     (76)
Shares exchanged for taxes on stock-based compensation (in shares) (39,402)        
Balance at end of period at Jun. 30, 2024 $ 309 156,860 (131,200) (2,182) 23,787
Balance at end of period (in shares) at Jun. 30, 2024 30,906,777        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     (5,617)   (5,617)
Unrealized (loss) income on foreign exchange rate translation       29 29
Stock-based compensation expense   45     45
Balance at end of period at Sep. 30, 2024 $ 309 156,905 (136,817) (2,153) 18,244
Balance at end of period (in shares) at Sep. 30, 2024 30,906,777        
Balance at beginning of period at Dec. 31, 2024 $ 310 157,073 (137,619) (2,483) $ 17,281
Balance at beginning of period (in shares) at Dec. 31, 2024 30,983,437       30,983,437
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     992   $ 992
Unrealized (loss) income on foreign exchange rate translation       (30) (30)
Stock-based compensation expense   44     44
Issuance of common stock as compensation (in shares) 1,050        
Shares exchanged for taxes on stock-based compensation (in shares) (325)        
Balance at end of period at Mar. 31, 2025 $ 310 157,117 (136,627) (2,513) 18,287
Balance at end of period (in shares) at Mar. 31, 2025 30,984,162        
Balance at beginning of period at Dec. 31, 2024 $ 310 157,073 (137,619) (2,483) $ 17,281
Balance at beginning of period (in shares) at Dec. 31, 2024 30,983,437       30,983,437
Increase (Decrease) in Stockholders' Equity          
Net (loss) income         $ (2,510)
Balance at end of period at Sep. 30, 2025 $ 310 157,115 (140,129) (2,107) $ 15,189
Balance at end of period (in shares) at Sep. 30, 2025 31,047,801       31,047,801
Balance at beginning of period at Mar. 31, 2025 $ 310 157,117 (136,627) (2,513) $ 18,287
Balance at beginning of period (in shares) at Mar. 31, 2025 30,984,162        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     (2,349)   (2,349)
Unrealized (loss) income on foreign exchange rate translation       477 477
Stock-based compensation expense   43     43
Issuance of common stock as compensation (in shares) 91,100        
Shares exchanged for taxes on stock-based compensation   (45)     (45)
Shares exchanged for taxes on stock-based compensation (in shares) (27,461)        
Balance at end of period at Jun. 30, 2025 $ 310 157,115 (138,976) (2,036) 16,413
Balance at end of period (in shares) at Jun. 30, 2025 31,047,801        
Increase (Decrease) in Stockholders' Equity          
Net (loss) income     (1,153)   (1,153)
Unrealized (loss) income on foreign exchange rate translation       (71) (71)
Balance at end of period at Sep. 30, 2025 $ 310 $ 157,115 $ (140,129) $ (2,107) $ 15,189
Balance at end of period (in shares) at Sep. 30, 2025 31,047,801       31,047,801